韩国政府宣布紧急投入额外预算，用于增购新冠药物以应对疫情复燃。总统室相关人士表示，政府正在积极应对新冠疫情的反弹，并已划拨准备金用于采购26万人份的新冠药物。这一举措旨在满足急剧增长的新冠药物需求，并已经开始额外供应口服药和注射剂。同时，政府正与药企协调具体的供应日程，以确保迅速引进新冠药物。此外，鉴于世界卫生组织（WHO）对猴痘病毒发布最高级别警报，政府将紧急召开危机评估会议，监控全球疫情并重点检查国内诊断和检疫等防疫体系。目前，韩国尚未发现猴痘病毒的相关异常情况，也未报告死亡病例。这一系列措施显示了韩国政府对于疫情防控的决心和积极应对疫情复燃的准备。
英语如下：
News Title: “South Korean Government Urgently Increases Purchases of COVID-19 Drugs to Combat Resurgence”
Keywords: Emergency Purchase, COVID-19, Resurgence
News Content: The South Korean government has announced an emergency allocation of additional budgetary funds to purchase more COVID-19 drugs in response to the resurgence of the pandemic. A presidential office official stated that the government is actively responding to the rebound of the COVID-19 situation and has allocated contingency funds for the procurement of 260,000 doses of COVID-19 drugs. This move is aimed at meeting the sharply increased demand for COVID-19 medications and has already begun supplying additional oral and injectable drugs. Additionally, the government is coordinating with pharmaceutical companies to ensure specific supply schedules, in order to swiftly introduce COVID-19 drugs.
Furthermore, in light of the World Health Organization (WHO) issuing its highest level of alert for the monkeypox virus, the government will hold an emergency crisis assessment meeting to monitor global outbreaks and to focus on checking the country’s diagnostic and quarantine systems. Currently, South Korea has not detected any unusual cases of the monkeypox virus and has not reported any deaths. These measures demonstrate the South Korean government’s determination to control the spread of the virus and its preparedness to respond to the resurgence of the pandemic.
【来源】https://cn.yna.co.kr/view/ACK20240816003400881?section=society/index&input=rss
Views: 1